Nuvation Bio News

Express News | NYSE Order Imbalance 56261.0 Shares on Sell Side

ReutersMay 3 15:50 ET

Express News | NYSE Order Imbalance 86897.0 Shares on Buy Side

ReutersMay 1 15:50 ET

Express News | NYSE Order Imbalance 104113.0 Shares on Sell Side

ReutersApr 30 15:50 ET

Nuvation Bio to Present Updated Data on Taletrectinib, a ROS1 Inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Nuvation Bio Inc. (NYSE:NUVB), a late-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced that

BusinesswireApr 24 10:01 ET

Express News | NYSE Order Imbalance 105723.0 Shares on Buy Side 105723.0 Shares on Buy Side

Moomoo 24/7Apr 19 15:50 ET

Fifth Third Bancorp Reports Upbeat Earnings, Joins Metropolitan Bank Holding, Paramount Global And Other Big Stocks Moving Higher On Friday

U.S. stocks were mixed, with the Nasdaq Composite falling over 100 points on Friday.Shares of Fifth Third Bancorp (NASDAQ:FITB) rose during Friday's session after the company reported better-than-expe

BenzingaApr 19 10:40 ET

Nuvation Bio Is Maintained at Outperform by RBC Capital

Nuvation Bio Is Maintained at Outperform by RBC Capital

Dow JonesApr 17 11:05 ET

Analysts Offer Insights on Healthcare Companies: Edgewise Therapeutics (EWTX), Healthequity (HQY) and Nuvation Bio (NUVB)

TipRanksApr 17 06:30 ET

Express News | Nuvation Bio Inc : RBC Raises Target Price to $5 From $4

Moomoo 24/7Apr 17 05:56 ET

Nuvation Bio Expands and Refreshes Leadership With Acquisition

TipRanksApr 10 16:24 ET

Nuvation Bio Will Continue to Be Led by Its Current Management Team >NUVB

Nuvation Bio Will Continue to Be Led by Its Current Management Team >NUVB

Dow JonesApr 10 16:07 ET

Nuvation Bio Transformed Into Late-Stage Global Oncology Co With Potential to Become Comml Organization by End of 2025 >NUVB

Nuvation Bio Transformed Into Late-Stage Global Oncology Co With Potential to Become Comml Organization by End of 2025 >NUVB

Dow JonesApr 10 16:05 ET

Nuvation Bio, AnHeart Shareholders Immediately Prior to Close Now Own About 67% and 33%, Respectively, of Nuvation Bio

Nuvation Bio, AnHeart Shareholders Immediately Prior to Close Now Own About 67% and 33%, Respectively, of Nuvation Bio

Dow JonesApr 10 16:04 ET

Nuvation Bio Completes Acquisition Of AnHeart Therapeutics >NUVB

Nuvation Bio Completes Acquisition Of AnHeart Therapeutics >NUVB

Dow JonesApr 10 16:01 ET

Intel, XPeng And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. stock futures were lower this morning, with the Nasdaq futures falling by around 0.2% on Wednesday. Shares of Intel Corporation (NASDAQ:INTC) fell sharply in today's pre-market trading after th

BenzingaApr 3 05:36 ET

Nuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial Officer

Business WireMar 28 08:00 ET

Analysts Offer Insights on Healthcare Companies: Santhera Pharmaceuticals Holding (OtherSPHDF), Nuvation Bio (NUVB) and Mereo Biopharma Group Plc (MREO)

TipRanksMar 28 06:30 ET

Express News | HC Wainwright & Co. Maintains Buy on Nuvation Bio, Raises Price Target to $8

Moomoo 24/7Mar 28 06:22 ET

Nuvation Bio Shares Jump After Jefferies Upgrade

Nuvation Bio (NUVB) shares jumped 39% in recent Wednesday trading after Jefferies upgraded the stock to buy from hold and boosted its price target to $10 from $1.40. Trading volume topped 10.7 million

MT NewswiresMar 27 15:46 ET

SMR, GCTS and GSIW Among Mid-day Movers

Seeking AlphaMar 27 13:22 ET